You have 9 free searches left this month | for more free features.

Tirzepatide

Showing 26 - 50 of 58

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type 2 Diabetes, Obesity Trial in Worldwide (Tirzepatide, Placebo)

Not yet recruiting
  • Type 2 Diabetes
  • Obesity
  • Tirzepatide
  • Placebo
  • Caba, Buenos Aires, Argentina
  • +48 more
Sep 8, 2023

Healthy Trial in Dallas (Tirzepatide, EE/NGM)

Completed
  • Healthy
  • Dallas, Texas
    Covance Dallas
Feb 17, 2021

Type 2 Diabetes Trial in Japan (Tirzepatide, Oral antihyperglycemic medication (OAM))

Completed
  • Type 2 Diabetes Mellitus
  • Tirzepatide
  • Oral antihyperglycemic medication (OAM)
  • Chiba-shi, Chiba, Japan
  • +33 more
Jan 21, 2022

Type2 Diabetes, Diabetes, Diabetes, Type 2 Trial in Worldwide (Tirzepatide Dose 1, Tirzepatide Dose 2, Placebo)

Recruiting
  • Type2 Diabetes
  • +7 more
  • Tirzepatide Dose 1
  • +2 more
  • Birmingham, Alabama
  • +55 more
Aug 8, 2022

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Insulin Glargine)

Completed
  • Type 2 Diabetes
  • Tirzepatide
  • Insulin Glargine
  • Blacktown, New South Wales, Australia
  • +66 more
Dec 12, 2022

Sleep Apnea, Obesity Trial in Worldwide (Tirzepatide, Placebo)

Recruiting
  • Sleep Apnea
  • Obesity
  • Tirzepatide
  • Placebo
  • Riverside, California
  • +66 more
Jan 23, 2023

Type 2 Diabetes Trial in United States (Tirzepatide, Placebo)

Completed
  • Type 2 Diabetes
  • Tirzepatide
  • Placebo
  • Fresno, California
  • +12 more
Apr 28, 2021

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Placebo)

Completed
  • Type 2 Diabetes
  • Tirzepatide
  • Placebo
  • Fresno, California
  • +47 more
Dec 12, 2021

Hepatic Insufficiency Trial in Tustin, Orlando, New Orleans (Tirzepatide)

Completed
  • Hepatic Insufficiency
  • Tirzepatide
  • Tustin, California
  • +2 more
Oct 6, 2020

Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)

Active, not recruiting
  • Obesity
  • Overweight
  • Tirzepatide
  • Placebo
  • Huntington Park, California
  • +64 more
Mar 22, 2022

Type 2 Diabetes, Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)

Active, not recruiting
  • Type 2 Diabetes
  • +2 more
  • Tirzepatide
  • Placebo
  • Birmingham, Alabama
  • +74 more
Apr 18, 2022

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Placebo)

Completed
  • Type 2 Diabetes Mellitus
  • Tirzepatide
  • Placebo
  • Huntington Park, California
  • +52 more
Oct 18, 2021

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Antihyperglycemic medication)

Not yet recruiting
  • Type 2 Diabetes
  • Tirzepatide
  • Antihyperglycemic medication
  • Birmingham, Alabama
  • +96 more
Aug 8, 2022

Nonalcoholic Steatohepatitis Trial in Worldwide (Tirzepatide, Placebo)

Recruiting
  • Nonalcoholic Steatohepatitis
  • Tirzepatide
  • Placebo
  • Birmingham, Alabama
  • +119 more
Aug 17, 2022

Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)

Active, not recruiting
  • Obesity
  • Overweight
  • Tirzepatide
  • Placebo
  • Pelham, Alabama
  • +69 more
Oct 5, 2021

Obesity, Heart Failure With Preserved Ejection Fraction Trial in Worldwide (Tirzepatide, Placebo)

Recruiting
  • Obesity
  • Heart Failure With Preserved Ejection Fraction
  • Tirzepatide
  • Placebo
  • Huntsville, Alabama
  • +144 more
Jan 18, 2023

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Insulin Lispro (U100), Insulin Glargine (U100))

Completed
  • Type 2 Diabetes
  • Tirzepatide
  • +2 more
  • Sheffield, Alabama
  • +134 more
Nov 22, 2022

Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)

Active, not recruiting
  • Overweight
  • Obesity
  • Tirzepatide
  • Placebo
  • Pelham, Alabama
  • +119 more
Apr 12, 2022

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Semaglutide)

Completed
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +126 more
Jan 21, 2022

Role Of Metabolic Adaptation In Weight Regain

Recruiting
  • Weight Loss
  • +2 more
  • Follow-up after intervention
  • Baton Rouge, Louisiana
    Pennington Biomedical Research Center
Mar 2, 2023

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Dulaglutide)

Active, not recruiting
  • Type 2 Diabetes Mellitus
  • Birmingham, Alabama
  • +646 more
Jan 18, 2023

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Insulin Degludec)

Completed
  • Type 2 Diabetes Mellitus
  • Tirzepatide
  • Insulin Degludec
  • Little Rock, Arkansas
  • +121 more
Jan 14, 2022

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Insulin Glargine)

Completed
  • Type 2 Diabetes Mellitus
  • Tirzepatide
  • Insulin Glargine
  • Anaheim, California
  • +215 more
Jan 21, 2022

Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)

Recruiting
  • Obesity
  • Overweight
  • Tirzepatide
  • Placebo
  • Gilbert, Arizona
  • +695 more
Jan 18, 2023

Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Type 2 Diabetes Trial in Al Ain (GIP/GLP-1a)

Not yet recruiting
  • Non-Alcoholic Fatty Liver Disease
  • +3 more
  • Al Ain, Abu Dhabi, United Arab Emirates
    Internal Medicine, College of Medicine and Health Sciences
Mar 1, 2023